Reprogramming the tumor microenvironment to boost adoptive T cell therapy. [PDF]
Meza Pacheco MF, Tai LH.
europepmc +1 more source
All‐Amyloid Functional Coacervates
This study introduces an all‐amyloid interfacial complex coacervate technique that employs charge‐mediated or functionalization‐assisted complexation of oppositely charged food protein‐derived amyloid nanofibrils to engineer functional soft constructs across multiple length scales.
Seyyed Alireza Hashemi +4 more
wiley +1 more source
Adoptive T-cell therapy for virus-associated diseases. [PDF]
Smith C, Khanna R.
europepmc +1 more source
Adoptive T-cell therapy targeting Epstein-Barr virus as a treatment for multiple sclerosis. [PDF]
Smith C, Khanna R.
europepmc +1 more source
Advanced Materials for Biologics Delivery to Brain Tumors
Material innovation is central to unlocking the therapeutic potential of biologics against many central nervous system diseases, including brain cancer. By engineering carriers with controlled transport, targeting, and release properties, advanced materials can overcome the blood–brain barrier and tumor microenvironment, improving the delivery of ...
Yuran Feng +4 more
wiley +1 more source
Advancing adoptive T cell therapy in ovarian cancer: barriers, innovations, and emerging platforms. [PDF]
Santos GNS +4 more
europepmc +1 more source
DNA origami-based artificial antigen-presenting cells for adoptive T cell therapy. [PDF]
Sun Y +6 more
europepmc +1 more source
Multi‐Stimuli Responsive Angstrom‐Scale Two‐Dimensional Channels of Natural Layered Materials
Å‐scale ion channels naturally formed within the interlayers of vermiculite clay enable ionic current modulation in response to mechanical, chemical, and electrical stimuli. Coupled pressure and electric fields induce reversible streaming current (Istream) polarity inversion, which is explained by a modified surface charge regulation model.
Raj Kumar Gogoi +5 more
wiley +1 more source
Extracellular ATP Functions as a Metabolic Lineage Selection Signal That Stabilizes Tc9 Cells During Adoptive T Cell Therapy. [PDF]
Ren J +7 more
europepmc +1 more source
Tyrosine kinase inhibitors as potential sensitizers of adoptive T cell therapy for hepatocellular carcinoma. [PDF]
Liang L +6 more
europepmc +1 more source

